Recent studies reveal that ACSL4 exhibits a dual role in cancer: while its lipid metabolic reprogramming promotes tumor progression, ACSL4 also exerts tumor-suppressive effects by driving ferroptosis, with its expression levels closely linked to cancer type, microenvironment, and therapeutic response (29). Here, ACSL4 is linked to cancer.